Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

INTRODUCTION: The long-term efficacy and safety of donepezil 10 mg in patients with dementia with Lewy bodies (DLB) were investigated in a 52-week Phase 3 trial. METHODS: This 52-week study consisted of 16-week randomized placebo-controlled (RCT) and 36-week open-label extension phases. Of 142 DLB p...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Res Ther
Главные авторы: Mori, Etsuro, Ikeda, Manabu, Nagai, Reiko, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338564/
https://ncbi.nlm.nih.gov/pubmed/25713600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0081-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы